Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD31 peptides for the treatment of thrombotic or autoimmune disorders

CD31 peptides for the treatment of thrombotic or autoimmune disorders

US Patent 10253085 · Granted Apr 9, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD31 shed as a molecular target for imaging of inflammation2021
CD31 shed as a molecular target for imaging of inflammation2021
CD31 peptides2020
CD31 peptides2020
Detection of platelet-derived shed CD312020
Detection of platelet-derived shed CD312020
Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, 2018
Detection of shed CD31, diagnosis of atherothrombosis and autoimmune disorders, 2018
Detection of platelet-derived shed CD312017
Detection of platelet-derived shed CD312017
CD31 peptides in the treatment of thrombotic and autoimmune disorders2015
CD31 peptides in the treatment of thrombotic and autoimmune disorders2015